Marcus John Drake MA, DM, FRCS

Dr. Marcus John Drake, MA, DM, FRCS is a Consultant Surgeon at the Bristol Urological Institute. He subspecialises in Female and Reconstructive Urology, Neurourology, and Urodynamics. He is also a Senior Lecturer in Urology at the University of Bristol, and Visiting Professor in Health and Applied Sciences at the University of the West of England. 

His major clinical studies are as Chief Investigator of the national randomized trial of urodynamics in male LUTS (UPSTREAM) and a study of melatonin for nocturia in MS (MeNiMS). He was the chief investigator of the multinational studies of combination therapy for male LUTS (NEPTUNE-2) and overactive bladder (besides). He leads a basic science research program in integrative neurophysiology and functional urology.

He is Chairman of the International Continence Society’s Standardisation Steering Committee, a board member of the European School of Urology, and of the European Society of Female and Functional Urology. He is also a member of the European Association of Urology Guidelines committee for Male LUTS, chairing the Guideline Development sub-group for Nocturia. In 2012, he chaired the Neurogenic Incontinence committee at the International Consultation on Incontinence and the Nocturia committee at the Consultation on Male LUTS. He is an advisor for the International Consultation on Incontinence Questionnaires (ICIQ).